Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microneedling vs. CGF in Female Androgenetic Alopecia
NCT06218394Recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Dec 2023
- Primary completion
- Sep 2024
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Randomised, open-label trial of concentrated growth factor in androgenetic alopecia (AGA), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Total Area Hair Count at week 24. Started Dec 2023; status: recruiting.
02
Drugs
concentrated growth factor
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT06218394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06218394.